Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alkido Pharma Inc (AIKI)

1.2998   -0.02 (-1.53%) 02-25 12:15
Open: 1.329 Pre. Close: 1.32
High: 1.42 Low: 1.27
Volume: 14,167,665 Market Cap: 45M
Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.442 - 1.45 1.45 - 1.458
Low: 1.251 - 1.26 1.26 - 1.269
Close: 1.306 - 1.32 1.32 - 1.333

Technical analysis

as of: 2021-02-25 11:41:43 AM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.32     One year: 2.98
Support: Support1: 1.07    Support2: 0.89
Resistance: Resistance1: 1.98    Resistance2: 2.55
Pivot: 1.64
Moving Average: MA(5): 1.41     MA(20): 1.61
MA(100): 0.89     MA(250): 0.85
MACD: MACD(12,26): 0.05     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 15.73     %D(3): 12.95
RSI: RSI(14): 46.06
52-week: High: 5.52  Low: 0.47  Change(%): 12.6
Average Vol(K): 3-Month: 1786223  10-Days: 3185253

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AIKI has closed above bottom band by 22.8%. Bollinger Bands are 210.3% wider than normal. The large width of the bands suggest high volatility as compared to AIKI's normal range. The bands have been in this wide range for 37 bars. This is a sign that the current trend might continue.

Headline News

Tue, 23 Feb 2021
Aikido Pharma Inc (AIKI) Stock Is Lower By -38.97% This Week: Buy, Hold, or Sell? - InvestorsObserver

Mon, 22 Feb 2021
AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus That Causes COVID-19 - Yahoo Finance

Fri, 19 Feb 2021
AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock - Yahoo Finance

Tue, 16 Feb 2021
AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment - PRNewswire

Tue, 16 Feb 2021
AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million - Yahoo Finance

Fri, 12 Feb 2021
Should You Buy Aikido Pharma Inc (AIKI) Stock Friday? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 29
% Held by Insiders 5.62
% Held by Institutions 13.10
Shares Short (K) 1,150
Shares Short P. Month (K) 691

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -92677.78
Return on Assets (ttm) -26.7
Return on Equity (ttm) -61.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -4
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 5154.19
Price to Cash Flow -10.62

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1980-05-11
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.